DL-2-Aminoheptanoic acid

DL-2-Aminoheptanoic acid is a seven-carbon, straight-chain amino acid derivative featuring a primary amino group and a carboxylic acid, with a stereogenic center at the 2-position that exists as a racemic mixture (DL). The aliphatic side chain provides a hydrophobic, conformationally flexible handle that can influence peptide backbone packing, membrane affinity, and substrate recognition in biochemical assays. The amino acid can participate in standard peptide coupling chemistry through activation of the carboxyl group and subsequent amide bond formation, while its functional groups enable controlled protection strategies for sequential synthesis. As a chiral precursor in racemic form, it can be resolved or derivatized to access enantioenriched building blocks, and it also serves as a practical intermediate for downstream functionalization of aliphatic amino acid motifs in synthetic organic chemistry and industrial fine chemical routes.

1. Peptide Building Block

DL-2-Aminoheptanoic acid is applied in peptide building block preparation where its amino and carboxylic acid functional groups support amide bond formation under peptide coupling conditions. The racemic 2-amino stereocenter and the hydrophobic heptyl side chain can be incorporated into linear peptides to probe how aliphatic chain length and stereochemical composition affect folding propensity and aggregation behavior. Protection of the amino group and conversion of the carboxyl group into an activated or protected derivative can enable stepwise N- to C-terminal peptide assembly without premature side reactions. Downstream, the resulting peptide analogs can be used as research substrates for biochemical characterization and as scaffold components in peptidomimetic design workflows.

2. Side-Chain Functionalization

DL-2-Aminoheptanoic acid is utilized in side-chain functionalization and amino acid derivatization strategies where the long aliphatic chain provides a tunable hydrophobic platform for further chemical transformation. The molecule's primary amine and carboxyl group can be selectively protected to direct functional group interconversions, enabling formation of N-substituted derivatives, esterified intermediates, or amide-linked conjugates for subsequent coupling chemistry. The stereogenic center can be retained during derivatization to preserve the amino acid's chiral information for later resolution or for stereochemical studies in synthetic methodology. Functionalized derivatives prepared from this amino acid can serve as intermediates for constructing hydrophobic linkers, amphiphilic motifs, and chemical biology probes that rely on aliphatic character for molecular recognition.

3. Chiral Resolution Intermediate

DL-2-Aminoheptanoic acid is employed as a chiral starting material in resolution and chiral auxiliary workflows aimed at accessing enantioenriched 2-aminoheptanoic acid derivatives. The presence of a single stereocenter at C-2 makes the compound amenable to formation of diastereomeric salts or derivatives that can be separated, after which the freed enantiomer can be carried forward into protected amino acid synthesis. N-protection and carboxyl activation can then be used to convert the resolved enantiomer into peptide-compatible building blocks for stereochemically defined incorporation. The resulting enantioenriched intermediates can support downstream applications in stereoselective peptide construction, chiral structure-property studies, and process chemistry development where consistent stereochemical identity is required.

4. Analytical Standard Development

DL-2-Aminoheptanoic acid is suitable for analytical research and method development as a racemic reference material for amino acid profiling, derivatization optimization, and chromatographic or spectrometric calibration. The defined amino acid backbone, with its primary amino and carboxylic acid groups, enables reproducible derivatization into detectable forms for techniques such as LC-based amino acid analysis or GC-compatible derivatives. Racemic composition can be leveraged to validate enantiomer separation performance when paired with chiral stationary phases or enantioselective derivatization reagents. Downstream, the compound can function as a control in quality-by-design studies for synthetic amino acid intermediates and in monitoring workflows for peptide building block preparation.

5. Pharmaceutical Intermediate Preparation

DL-2-Aminoheptanoic acid is applied in pharmaceutical intermediate preparation and fine chemical synthesis where its aliphatic amino acid structure can be transformed into protected amino acid derivatives, amide intermediates, and hydrophobic linker components. The amino and carboxyl functionalities support standard protection-group strategies that align with peptide coupling compatibility, enabling incorporation into larger synthetic sequences that require controlled handling of reactive groups. The hydrophobic heptyl side chain can be used to tune physicochemical properties of downstream molecules, including lipophilicity and conformational behavior in structure-activity relationship studies. Industrially, the compound can serve as a feedstock-like chiral precursor for manufacturing routes that require aliphatic amino acid motifs, including intermediate generation for specialty chemical production and applied medicinal chemistry synthesis.

1. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

4. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction